Literature DB >> 18550205

Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.

Zhi-Hong Zhao1, Sheng-Fa Wang, Liang Yu, Ju Wang, Hao Chang, Wei-Li Yan, Jian Zhang, Kai Fu.   

Abstract

BACKGROUND: Transcription factor Pokemon, a central regulation gene of the important tumor suppressor alternative reading frame (ARF), exerted its activity by acting upstream of many tumor-suppressing genes and proto-oncogenes. Its expression in non-small cell lung cancer (NSCLC) and its clinical significance remains unclear. The aim of this study was to investigate the expression of Pokemon in non-small cell lung cancer and to explore its correlation with the clinical pathological characteristics and its influence on patients' prognosis. AIM: Observe the expression of Pokemon in NSCLC and investigate its mechanism and clinical significance.
METHODS: Determine the expression of Pokemon in human NSCLC cell lines as well as 55 cases of NSCLC tumor tissues, tumor adjacent tissues and surrounding tissues by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot, and analyze the relationship between Pokemon expression in NSCLC tumor tissues and clinicopathological features. Determine 62 NSCLC tumor tissues (5 years ago) and p14(ARF) expression with immunohistochemical technique, discuss the correlation between them and assess the effect of Pokemon on prognosis of patients with lung cancer.
RESULTS: Pokemon mRNA and protein took on high expression in lung cancer cell lines, and the expression difference between cancer tissues, tumor adjacent tissues and surrounding tissues had statistical significance (P<0.05). Pokemon expression and p14(ARF) expression were negatively correlated (r=-0.287). The expression of Pokemon was determined not to be associated with the patient's sex, age, smoking condition, tumor differentiation degree, histology and lymph node metastasis condition. However, its relationship with TNM staging was established (P<0.05). Furthermore, it was shown that the survival rate of patients with negative Pokemon expression was significantly higher than that of those with positive Pokemon expression (P=0.004), therefore, the expression of Pokemon is believed to be an independent factor affecting prognosis (P=0.034).
CONCLUSION: There was high expression of Pokemon in NSCLC, Pokemon exerted carcinogenesis by inhibiting ARF and had some clinical significance for prognostic evaluation of the patients with NSCLC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550205     DOI: 10.1016/j.lungcan.2008.02.014

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  15 in total

1.  Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway.

Authors:  Yi Zhao; Yun-hong Yao; Li Li; Wei-fang An; Hong-zen Chen; Li-ping Sun; Hai-xian Kang; Sen Wang; Xin-rong Hu
Journal:  Med Oncol       Date:  2014-11-04       Impact factor: 3.064

2.  Resveratrol Represses Pokemon Expression in Human Glioma Cells.

Authors:  Yutao Yang; Jiajun Cui; Feng Xue; Anne-Marie Overstreet; Yiping Zhan; Dapeng Shan; Hui Li; Hui Li; Yongjun Wang; Mengmeng Zhang; Chunjiang Yu; Zhi-Qing David Xu
Journal:  Mol Neurobiol       Date:  2015-01-27       Impact factor: 5.590

3.  The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder.

Authors:  Changcheng Guo; Dabo Xiong; Bin Yang; Haiming Zhang; Wenyu Gu; Min Liu; Xudong Yao; Junhua Zheng; Bo Peng
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

4.  Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers.

Authors:  Anshu Aggarwal; William J Hunter; Himanshu Aggarwal; Edibaldo D Silva; Mary S Davey; Richard F Murphy; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-05-21       Impact factor: 3.362

5.  Epidermal growth factor increases LRF/Pokemon expression in human prostate cancer cells.

Authors:  Himanshu Aggarwal; Anshu Aggarwal; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2011-05-27       Impact factor: 3.362

6.  Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival.

Authors:  D Dayde; M Guerard; P Perron; A-S Hatat; C Barrial; B Eymin; S Gazzeri
Journal:  Oncogene       Date:  2015-12-21       Impact factor: 9.867

7.  The BTB-ZF family of transcription factors: key regulators of lineage commitment and effector function development in the immune system.

Authors:  Aimee M Beaulieu; Derek B Sant'Angelo
Journal:  J Immunol       Date:  2011-09-15       Impact factor: 5.422

Review 8.  Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!

Authors:  Ruju Vashi; Bhoomika M Patel
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

9.  Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes.

Authors:  Yingqiu Xie; Sanzhar Naizabekov; Zhanlin Chen; Tursonjan Tokay
Journal:  Oncol Lett       Date:  2016-05-26       Impact factor: 2.967

Review 10.  Role of LRF/Pokemon in lineage fate decisions.

Authors:  Andrea Lunardi; Jlenia Guarnerio; Guocan Wang; Takahiro Maeda; Pier Paolo Pandolfi
Journal:  Blood       Date:  2013-02-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.